These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 4198306

  • 1. Clorazepate dipotassium, diazepam and placebo in chronic anxiety.
    Feurst SI.
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):449-59. PubMed ID: 4198306
    [No Abstract] [Full Text] [Related]

  • 2. Clorazepate dipotassium in anxiety: a double-blind trial with diazepam controls.
    Wiersum J.
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):442-8. PubMed ID: 4629306
    [No Abstract] [Full Text] [Related]

  • 3. Controlled trial of dipotassium clorazepate ("Tranxene") in anxiety.
    Cooper AJ, Magnus RV, Rose M, Phanjoo A, Lancaster NP, Pollard P, Knowlson P.
    Br J Psychiatry; 1973 Oct; 123(575):475-6. PubMed ID: 4584032
    [No Abstract] [Full Text] [Related]

  • 4. A multicenter investigation of lorazepam in anxiety neurosis.
    Nanivadekar AS, Wig NN, Khorana AB, Master RS, Kulkarni SS.
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):500-7. PubMed ID: 4198313
    [No Abstract] [Full Text] [Related]

  • 5. Chlorazepate dipotassium in the treatment of anxiety associated with chronic gastrointestinal disease.
    Kasich AM.
    Curr Ther Res Clin Exp; 1973 Mar; 15(3):83-91. PubMed ID: 4196231
    [No Abstract] [Full Text] [Related]

  • 6. Once-a-day potassium clorazepate in anxiety.
    Magnus RV.
    Br J Clin Pract; 1973 Dec; 27(12):449-52. PubMed ID: 4590788
    [No Abstract] [Full Text] [Related]

  • 7. [Comparative study of the anxiolytic efficacy of lorazepam (WY 4036) and diazepam (Valium)].
    De Buck R, Boon H, Pelc I.
    Acta Psychiatr Belg; 1972 Mar; 72(2):185-98. PubMed ID: 4560256
    [No Abstract] [Full Text] [Related]

  • 8. Clorazepate (tranxene). Another benzodiazepine.
    Med Lett Drugs Ther; 1972 Nov 10; 14(23):85-6. PubMed ID: 4630756
    [No Abstract] [Full Text] [Related]

  • 9. Clorazepate dipotassium in anxiety: a clinical trial with diazepam and placebo controls.
    Ricca JJ.
    J Clin Pharmacol New Drugs; 1972 Jul 10; 12(7):286-90. PubMed ID: 4557537
    [No Abstract] [Full Text] [Related]

  • 10. Clinical trial of dipotassium chlorazepate, a new benzodiazepine derivative.
    Juhlin L, Opitz B.
    Nord Psykiatr Tidsskr; 1973 Jul 10; 27(1):35-9. PubMed ID: 4569218
    [No Abstract] [Full Text] [Related]

  • 11. A comparison of lorazepam, diazepam and placebo in the treatment of anxiety states.
    Singh AN, Saxena B.
    Curr Ther Res Clin Exp; 1974 Mar 10; 16(3):149-62. PubMed ID: 4206723
    [No Abstract] [Full Text] [Related]

  • 12. Clinical and physiological assessment of chlorazepate, diazepam and placebo in anxious neurotics.
    Lapierre YD.
    Int J Clin Pharmacol Biopharm; 1975 Jun 10; 11(4):315-22. PubMed ID: 239907
    [Abstract] [Full Text] [Related]

  • 13. Clinical and computerized EEG effects of U-31,920, a new anxiolytic.
    Itil TM, Akpinar S, Ozkut H, Balki N, Herrmann WM.
    Curr Ther Res Clin Exp; 1974 Jun 10; 16(6):642-54. PubMed ID: 4211146
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of prazepam and placebo in the treatment of convalescing narcotic addicts.
    Sugerman AA, Miksztal MW, Freymuth HW.
    J Clin Pharmacol New Drugs; 1971 Jun 10; 11(5):383-7. PubMed ID: 4935717
    [No Abstract] [Full Text] [Related]

  • 15. SCH-12,041, a new anti-anxiety agent (quantitative pharmaco-electroencephalography and clinical trials).
    Itil T, Gannon P, Cora R, Polvan N, Akpinar S, Elveris F, Eskazan E.
    Behav Neuropsychiatry; 1972 Jun 10; 4(4-5):15-24. PubMed ID: 4566673
    [No Abstract] [Full Text] [Related]

  • 16. [Trial of dipotassium chlorazepate in child psychiatry].
    Launay C, Houzel D.
    Rev Neuropsychiatr Infant; 1972 May 10; 20(5):491-5. PubMed ID: 5081843
    [No Abstract] [Full Text] [Related]

  • 17. Double-blind evaluation of prazepam, chlordiazepoxide and placebo in non-psychotic patients with anxiety and tension: some methodological considerations.
    Kingstone E, Villeneuve A, Kossatz I.
    Curr Ther Res Clin Exp; 1969 Mar 10; 11(3):106-14. PubMed ID: 4976238
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical experimentation with lorazepam (Temesta) in ambulatory practice].
    Aflalo M, Berkowitch S, Thielemans G, Vermeylen J.
    Acta Psychiatr Belg; 1972 Nov 10; 72(6):756-66. PubMed ID: 4679558
    [No Abstract] [Full Text] [Related]

  • 19. SCH 12041. A new antianxiety agent.
    Gallant DM, Bishop MP.
    Curr Ther Res Clin Exp; 1971 Feb 10; 13(2):107-10. PubMed ID: 4994212
    [No Abstract] [Full Text] [Related]

  • 20. Somatosensory evoked potential: an objective indicator of the therapy efficacy of a new psychotropic drug, clorazepate dipotassium (tranxene).
    Saletu B, Saletu M, Itil TM.
    Curr Ther Res Clin Exp; 1972 Aug 10; 14(8):428-41. PubMed ID: 4629305
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.